Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
The HemOnc Pulse
00:00
Introduction
Dr. Krish Patel shares insights on lymphoid malignancies, emphasizing the evolving frontline treatment approaches for DLBCL with a focus on the influence of Polaris data and the adoption of polatuzumab-based therapy for non-germinal center B cell DLBCL.
Transcript
Play full episode
